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Abstract
During the final stages of erythropoiesis, lineage-restricted progenitors mature over three to five cell divisions,
culminating with withdrawal from the cell cycle and the loss of most organelles, including mitochondria and
nuclei. Recent genome-wide association studies in human populations have associated several SNPs near or within
FBXO7 with erythrocyte phenotypes. Fbxo7 encodes a multi-functional F-box protein known to bind p27 and
participate in selective mitophagy. One SNP causes an amino acid substitution (Met115Ile) and is associated with
smaller erythrocytes. We find that the less common IIe115 allele of Fbxo7 binds less efficiently to p27, and cells
expressing this allele proliferate faster than cells expressing Met115. We show that an erythroleukaemic cell line
with reduced Fbxo7 expression fails to stabilize p27 levels, exit the cell cycle, and produce haemoglobin. In addition,
mice deficient in Fbxo7 expression are anaemic due to a reduction in erythrocyte numbers, and this is associated
with lower p27 levels, increased numbers of late-stage erythroblasts with greater than 2N DNA content, and
delayed mitophagy during terminal differentiation. Collectively, these data support an important physiological,
cell cycle regulatory role for Fbxo7 during erythropoiesis.
© 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
The daily production of erythrocytes requires massive
progenitor cell expansion to generate vast numbers
of erythroblasts (EBs), followed by cell cycle with-
drawal at the final stages of differentiation, when
haemoglobinization and cellular remodelling occur.
Careful regulation of the G1 phase is crucial for erythro-
poiesis, and both pro-proliferative and anti-proliferative
activities are essential. This is evidenced in mice with
aberrant expression of CDK6, cyclin D3, and cyclin E,
which show ineffective erythropoiesis and/or anaemia
[1–3]. In addition, removal of organelles, including
the mitochondrial network, is part of this differenti-
ation process [4,5]. In erythrocytes, the Nix/BNip3L
pathway regulates mitophagy by bridging mitochon-
dria to LC3/GABARAP, recruiting mitochondria into
autophagosomes [6]. Knockout mouse models lack-
ing Nix or other autophagy regulators, such as Atg7
or Ulk1, develop anaemia, due to aberrant retention
of mitochondria in erythrocytes, increased ROS, and
decreased red blood cell (RBC) survival (reviewed in
Mortensen et al [7]).
F-box proteins (FBPs) confer selectivity to SCF
(Skp1–Cullin–FBP)-type E3 ubiquitin ligases,
enabling the ubiquitination of recruited substrates.
This 69-member family is engaged in a range of
activities, many of which are critically important for
normal cellular functions [8]. We previously reported
alterations in EB numbers in the bone marrow (BM)
of mice with a disrupted Fbxo7 (F-box protein only
7) gene (Fbxo7LacZ/LacZ) [9]. They showed increased
numbers of early-stage EBs and decreased late-stage
EBs [9]. More recently, multiple genome-wide associa-
tion studies (GWASs) have correlated single nucleotide
polymorphisms (SNPs) in human FBXO7 with alter-
ations to RBC parameters, suggesting that FBXO7
affects erythropoiesis [10–12].
FBXO7/PARK15 is implicated in many human dis-
eases, including cancers and early-onset Parkinson’s
disease [13]. Its involvement in such a variety of dis-
eases indicates that its activities are fundamental in
many specialized cells. However, the mechanisms caus-
ing dysfunction within individual cell types vary and
are not fully understood. FBXO7 is a versatile protein
that in addition to being part of an E3 ligase (ubiqui-
tinating proteins such as c-IAP, HURP, and TRAF2)
also has non-canonical functions, including acting as a
cell cycle regulator by interacting with Cdk6 and p27,
and putatively as a regulator of proteasome activity via
© 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
264 SJ Randle et al
interaction with PI31. Fbxo7 also regulates stress-
induced mitophagy via its direct interaction with Parkin
and PINK1 (reviewed in Nelson et al [13]). Given
the numerous GWASs and reported roles for FBXO7
as a regulator of both G1 phase and mitophagy, we
hypothesized that it would regulate erythropoiesis and
set out to identify the molecular pathways responsible.
Here we report studies of mice with a disrupted Fbxo7
locus that support an important, physiological, cell
cycle regulatory role for Fbxo7 during erythropoiesis.
Materials and methods
GST binding assays
In vitro binding assays were performed as described
previously [14].
Cell culture
MEL cells were maintained in DMEM, 10% FBS,
2mM glutamine, 100U/mL penicillin-streptomycin
(Life Technologies, Paisley, Renf, UK). MEL cells
were transfected with miR30-based short-hairpin
vectors targeting murine Fbxo7 or empty vector as
described [15], or infected using MSCV-based vectors
to express human Fbxo7 as described [9]. To induce
differentiation, MEL cells were passaged daily in 1.5%
DMSO (Sigma, Gillingham, Dorset, UK) at a density
of 1× 106 cells/ml. Haemoglobin quantification using
benzidene hydrochloride colorimetric assay was per-
formed as previously described [16]. Proliferation was
determined by calculating the log2 cell increase, plotted
as cumulative population doublings (PD) over time, and
inferred using line of best fit.
For blood cultures, 1 μl of EDTA-treated whole blood
was cultured with or without 30 μM CCCP (Sigma)
or 160 μM bafilomycin A1 in reticulocyte media [17].
Colony-forming assays were performed according to
themanufacturer’s instructions (StemCell Technologies,
Grenoble, France).
Mice
Animals were housed in accordance with Home Office
regulations. Tissue was harvested at 6 weeks, unless oth-
erwise stated. Complete blood counts were performed
using a Scil Vet automatic blood counter, and blood
smears stained with HemaColor (Merck Millipore, Wat-
ford, Herts, UK).
Flow cytometry
Suppliers of antibodies and dyes were as follows:
eBioscience (Hatfield, Herts, UK): CD71-biotin,
Ter119-PE, CD48-APC, CD150-PECy7, CD34-
APC, FcγRII/III-PECy7, IL7Rα-PECy7, Flk3-PE,
CD44-biotin, streptavidin-APC; Life Technologies
(Paisley, Renf, UK): biotinylated lineage cocktail
(MLM15), c-kit-APC-Cy7, Mac1-biotin, Gr1-PE;
BioLegend (London, UK): Sca-1-PB. Mitochondria
were stained with 500 nM Mitotracker DeepRed (Invit-
rogen) for 30min at 37 ∘C in complete media. For cell
cycle analysis, Click-IT EdU was used (Invitrogen) or
for primary cells, 3× 105 cells were sorted, fixed in 70%
ethanol, and stained in 1× PBS, 50 μg/ml PI, 50 μg/ml
RNase A.
Cell fractionation and immunoblotting
For fractionations, equal cell numbers were lysed in
100 μl of RSB buffer (10mM Tris, pH 7.4; 100mM
NaCl; 25mM MgCl2, 40 μg/ml digitonin; protease and
phosphatase inhibitors) for 10min with rotation. Lysates
were passed through a 25G needle and centrifuged at 13
000 rpm for 15min. Supernatants were kept as cytoso-
lic fraction, and the pellet was lysed in 50 μl of RIPA
buffer with protease and phosphatase inhibitors. Anti-
bodies for immunoblotting were as follows: Santa Cruz
Biotechnology (Heidelberg, Germany): CDK6 (sc-177),
CDK4 (sc-260), CDK2 (sc-163), p27 (sc-528); Cell
Signaling (Danvers, MA, USA): PINK1 (6946), LC3B
(2775), GAPDH (2118), Nix (9089), p62 (5114); Sigma:
actin, Ponceau S; Abcam (Cambridge, Cambs, UK):
Parkin (ab15954), Apotrack; and Fbxo7 as previously
described [18].
Immunoprecipitation (IP) and kinase assays
For kinase assays, 1× 107 cells were lysed in 500 μl
of ELB buffer (50mM HEPES, pH 7.5; 160mM NaCl;
5mM EDTA; 0.1% NP-40, 1× protease inhibitors;
1mM PMSF), and for co-IPs, 5–10× 106 cells were
lysed in RIPA buffer. For IPs, 1 μg of anti-CDK2 or
IgG, with 20 μl of Protein A/G agarose (Santa Cruz
Biotechnology), or 20 μl of EZview anti-HA beads
(Sigma) was used as previously described [9]. Beads
were washed with kinase buffer (25mMHEPES, pH 7.5;
5mM MgCl2; 2.5mM MnCl2; 0.5mM DTT) prior to
adding 0.75 μg of recombinant 6×His-Rb (amino acids
792–928; ProSpec, Ness-Ziona, Israel), 37.5 μM ATP,
and 1 μCi of [γ-33P]ATP for 30min at 30 ∘C. Samples
were resolved by SDS-PAGE; gels were fixed in 10%
acetic acid/methanol, dried, and quantified using a
Cyclone Phosphor Imager (PerkinElmer, Waltham,
MA, USA).
Results
Mice with reduced Fbxo7 are anaemic
To characterize erythropoiesis in Fbxo7LacZ/LacZ
mice, we analysed cell populations giving rise to
this lineage. Haematopoietic stem cells (HSCs) and
multipotent progenitor (MPP) populations within the
BM were counted. The percentages of Lineage−,
Sca-1+, c-Kit+ (LSK) cells and MPPs arising from
long-term HSCs (LT-HSCs), including short-term
HSCs, lymphoid-primed MPPs (LMPPs), and common
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lymphoid progenitors (CLPs), were unchanged (Sup-
plementary Figure 1A). However, LT-HSCs enriched
within the LSK, CD150+, CD48− compartment [19]
were reduced on average by 38% in Fbxo7LacZ/LacZ
mice compared with sex- and litter-matched controls
(Figure 1A). Among lineage-defined progenitors,
no differences were seen in the common myeloid
progenitors (CMPs) and granulocyte/macrophage pro-
genitors (GMPs) by antibody staining (Supplementary
Figure 1B) or by methylcellulose assays for myeloid
colony-forming units (CFUs) (Figure 1B). There was a
significant 12% increase in the percentage of megakary-
ocytic/erythroid progenitors (MEPs) in Fbxo7LacZ/LacZ
mice (Figure 1C). As previously reported, the number
of erythroid progenitors was significantly increased
as shown by methylcellulose assays and by antibody
staining for CD71 and Ter119, which also showed
that Fbxo7LacZ/LacZ mice had fewer late-stage EBs
(independent experiments in Supplementary Figures
1C and 1D) [9]. The CD71−, Ter119hi population also
contains enucleated reticulocytes and mature RBCs.
An alternative staining protocol dependent on CD44,
Ter119 expression and cell size [20] can therefore be
used to delineate orthochromatophilic EBs (population
IV-A) from reticulocytes (IV-B) and RBCs (V). Using
this method, we determined that the major population
significantly reduced in Fbxo7LacZ/LacZ mice was mature
RBCs (Figures 1D and 1E). This method also identified
elevated numbers of erythroid progenitors (populations
I, II, and III). The two methods showed a difference with
regard to numbers of maturing EBs, which were not
different between genotypes using CD71/Ter119 stain-
ing (CD71mid, Ter119hi) (Supplementary Figure 1D),
compared with population III using CD44/Ter119/FSC
(Figures 1D and 1E). This may reflect the greater over-
lap of populations I/II/III when CD71 staining is used
to delineate this polychromatophilic (poly)-EB popu-
lation. Nonetheless, both staining protocols indicated
an increased number of earlier stage progenitors, yet
a reduction in later stage cells including RBCs in the
BM of Fbxo7LacZ/LacZ mice. Importantly, while charac-
terizing EB populations and other tissues in Fbxo7LacZ
mice, we noted that homozygous LacZ did not ablate
Fbxo7 expression (Supplementary Figures 1E and 1 F).
Therefore, this mouse was not a true null.
Given the marked reduction in RBCs in the BM, we
performed complete blood counts. Fbxo7LacZ/LacZ mice
were anaemic, with a significantly reduced haematocrit
(HCT) and a 26% reduction in RBCs (Figure 2A). This
decrease correlated with reduced blood haemoglobin
(HGB) concentration. In addition, the MCV and con-
centration of HGB per cell (MCHC) were significantly
elevated, with changes in the RBC distribution width
(RDW) also evident. Parameters for leukocytes and
platelets in Fbxo7LacZ/LacZ mice were not significantly
altered, and heterozygous mice were comparable to
WT. Fbxo7LacZ/LacZ mice also showed reticulocytosis
(Figure 2B), evident in blood smears, which showed a
high proportion of immature, larger, polychromatophilic
Figure 1. Analysis of stem and multipotent progenitor, and
erythroid-specific precursor populations in Fbxo7LacZ/LacZ mice.
(A) Percentage of LT-HSCs (Lineage−, Sca-1+, c-kit+, CD150+,
CD48−) in the BM of wild-type (WT) and Fbxo7LacZ/LacZ (LacZ)
mice. (B) Number of colony-forming units (CFU) per 2× 104 BM
cells after 10 days in culture. CFU-M: macrophage; −G: gran-
ulocyte; −GM: mixed granulocyte/macrophage; −GEMM: mixed
granulocyte/erythroid/macrophage/megakaryocyte. (C) Percentage
of megakaryocyte-erythroid progenitors (MEP; Lineage−, Sca-1−,
c-kit+, CD34−, FcγRII/III−) in the BM. (D) Percentage of EBs in the
BM of WT and LacZ animals (n= 9), defined using CD44, Ter119,
and cell size to differentiate enucleated cells from ortho-EBs,
as described by Chen et al [20]. I= pro-EBs; II= basophilic
EBs; III= polychromatophilic EBs; IV-A= orthochromatophilic EBs;
IV-B= reticulocytes; V=mature RBCs. (E) Representative flow
cytometry plots of the gating strategy used in D. Ter119hi cells were
used for CD44 v forward scatter (FS) analysis. For all figures, values
are mean± standard deviation. *p< 0.05; **p< 0.01; ***p< 0.001.
cells (Figure 2C, arrows). Anaemia persisted through-
out the lifespan of Fbxo7LacZ/LacZ mice, with additional
changes in platelet volume (MPV) becoming apparent
by 15 months (Figure 2D).
Anaemia can induce extramedullary haematopoiesis
(EMH), and consistent with this, spleens from
Fbxo7LacZ/LacZ mice were 69% larger than those from
WT or heterozygous mice (Figure 2E). Extensive EMH
was seen histologically in spleen sections, while the
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Figure 2. Fbxo7LacZ/LacZ mice are anaemic. (A) Analysis of blood parameters in 4- to 6-month-old WT, heterozygous (Het), and
Fbxo7LacZ/LacZ (LacZ) mice. HCT= haematocrit; RBC= number of erythrocytes per millilitre of blood; MCV=mean erythrocyte cell vol-
ume; HGB= haemoglobin concentration in blood; MCHC= haemoglobin concentration per cell; RDW= red blood cell distribution width;
Lym= lymphocyte number; Mono=monocyte number; Gran= granulocyte number; Platelets= platelet number per millilitre of blood;
MPV=mean platelet volume. (B) Reticulocyte index (n= 9). (C) Blood smears stained with HemaColor, with arrows indicating larger, imma-
ture, polychromatophilic cells. (D) Blood counts of 15- to 17-month-old mice. (E) Graph of average spleen mass of WT (n= 5), Het (n= 8),
and LacZ (n= 11) mice. (F) H&E-stained spleen sections from WT and LacZ mice showing extramedullary haematopoiesis (bar= 200 μm).
(G) Number of erythroid colony-forming units (CFU-E) per 2× 105 spleen cells after 3 days in culture (n= 3, in duplicate). (H) Epo mRNA
expression in kidneys of WT and LacZ mice relative to cyclophilin A (n= 4).
white pulp architecture was unperturbed (Figure 2F).
When assayed by methylcellulose assays, spleens
from Fbxo7LacZ/LacZ mice had 2.4-fold more erythroid
CFUs compared with WT (Figure 2G), as well as ele-
vated numbers of other myeloid CFUs (Supplementary
Figure 1G).
Erythropoietin (Epo) levels were assayed in the kid-
neys by qRT-PCR (Figure 2H). Fbxo7LacZ/LacZ mice had
8.8 times the amount of Epo mRNA compared with lit-
termate controls, eliminating deficient Epo production
as a cause of anaemia. However, a defect in Epo sig-
nalling cannot be ruled out.
Fbxo7 stabilizes p27 to enable cell cycle arrest
To investigate the mechanistic basis for the anaemia, we
exploited the ability of murine erythroleukaemia (MEL)
cells to partially recapitulate erythroid differentiation
in vitro [21]. Fbxo7 expression was reduced using a
previously validated shRNA construct [9]; cells were
differentiated by DMSO treatment; and haemoglobin
concentration was measured over time (Figure 3A).
Control cells accumulated haemoglobin over 5 days,
whereas cells expressing Fbxo7 shRNA (Fbxo7-sh) did
not, demonstrating a requirement for Fbxo7 in MEL dif-
ferentiation.
Proliferation rates during differentiation were also
measured (Figure 3B). Fbxo7-sh cells proliferated at the
same rate as control cells under normal culture condi-
tions (− DMSO), indicating that Fbxo7 did not affect
proliferation. When induced (+ DMSO), control cells
slowed proliferation by day 4, while Fbxo7-sh cells con-
tinued to divide. The number of cells in the S phase
was determined by staining for EdU incorporation and
DNA content. In control cells, 35.1% had 2N DNA
content (G0/G1 phase) under control conditions, which
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Figure 3. Fbxo7 is required for the differentiation of MEL cells by
stabilizing p27 expression. (A) MEL cells expressing an empty vec-
tor shRNA (vector-sh) or Fbxo7-specific shRNA vector (Fbxo7-sh)
were induced to differentiate over 5 days and the haemoglobin
concentration was determined using benzidine colorimetric assay
(n= 3). (B) Proliferation rate, as measured by population doubling
over time, of MEL cells expressing vector-sh or Fbxo7-sh, with (+
DMSO) or without (− DMSO) differentiation-inducing agent (n= 3).
(C) Immunoblots of whole cell lysates of cells described in B. (D)
Immunoblots of anti-CDK2 or IgG immunoprecipitates from MEL
cells expressing vector-sh or Fbxo7-sh, with or without 6 days of
DMSO treatment. Whole cell lysate prior to immunoprecipitation
was used for input. (E) Radiograph of radiolabelled phospho-pRb
phosphorylated using immunoprecipitated CDK2 or IgG control,
from MEL cells expressing vector-sh or Fbxo7-sh, with or without
6 days of DMSO treatment. Quantification of CDK2 kinase activity,
relative to untreated control cells, is below the image.
increased to 71.8% after 6 days of DMSO treatment,
indicating G1 arrest. However, Fbxo7-sh cells had sim-
ilar percentages of cells in the G0/G1 phase, irrespec-
tive of treatment (35.2% untreated; 37% DMSO). These
data demonstrate that Fbxo7-sh cells failed to arrest cell
cycle.
To investigate which cell cycle regulators were
affected, cell lysates were immunoblotted (Figure 3C).
Neither CDK2 nor CDK4 showed any appreciable
differences during differentiation, nor were there any
differences between the two cell lines. Down-regulation
of CDK6 occurs during MEL differentiation [22], and
this was observed in control cells and was largely
unaffected by reduced Fbxo7 expression. However, a
clear difference in p27 levels was seen: in control cells,
p27 expression increased starting at 3 days, but it was
absent from Fbxo7-sh cells, indicating that Fbxo7 was
necessary for p27 accumulation.
The consequences of a failure to accumulate p27
were investigated by determining its association with
CDK2 (Figure 3D). During normal culture, p27 was
not detected. When control cells were differentiated,
p27 was readily detected bound to CDK2, but this was
reduced by 53.5% in Fbxo7-sh cells, when normalized
to immunoprecipitated CDK2. This was in line with
the 67% reduction in total levels of p27 detected in
Fbxo7-sh cells compared with control cells. Fbxo7 was
not immunoprecipitated with CDK2, suggesting that it
increases the available pool of p27 in cells via inde-
pendent interactions. We next analysed CDK2 activ-
ity using kinase assays (Figure 3E). In DMSO-treated
control cells, CDK2 activity decreased by an average
of 72% (p< 0.001), while Fbxo7-sh cells showed only
a 25% reduction in activity after DMSO treatment,
which was not significantly different from untreated
cells (p= 0.08). These data are consistent with a model
whereby Fbxo7 stabilizes p27 levels, which inhibits
CDK2 and promotes cell cycle withdrawal.
Fbxo7LacZ/LacZ mice have less p27
As suggested by the MEL experiments, we next inves-
tigated whether a failure to withdraw from the cell
cycle was evident in EBs from Fbxo7LacZ/LacZ mice.
To test this, EB populations were sorted using the
CD71/Ter119 method, as this gave distinct flow cytom-
etry populations, and the DNA content in nucleated cells
was quantified, which excluded reticulocytes and RBCs
from analysis. The percentage of EBs with greater
than 2N DNA content, suggestive of proliferation, was
increased in the late-stage CD71−, Ter119hi population
in Fbxo7LacZ/LacZ mice (Figure 4A). Moreover, we found
significantly fewer early-stage EBs with greater than
2N DNA content (CD71hi, Ter119lo), even though
they were increased in number in Fbxo7LacZ/LacZ mice
(Supplementary Figure 1D).
We next tested for expression of cell cycle regulators
in these sorted populations (Figure 4B). Fbxo7 protein
was 71–99% reduced in Fbxo7LacZ/LacZ mice (Supple-
mentary Figure 1H). G1 CDKs were all down-regulated
during differentiation, but of these, CDK2 was still
expressed at the later EB stages. We found that p27
was reduced in late-stage EBs from Fbxo7LacZ/LacZ
mice compared with WT, while no difference was
seen in early-stage EBs between genotypes. This was
independently repeated (Figure 4C) and quantified to
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Figure 4. CD71− Ter119hi EBs in Fbxo7LacZ/LacZ mice have increased numbers of cells with greater than 2N DNA content and less p27. (A)
Percentage of cells with greater than 2N DNA content using propidium iodide staining, in EB populations using CD71 and Ter119 staining
(WT n= 5, LacZ n= 4). (B) Immunoblots of whole cell lysates from equal numbers of sorted EBs from WT and LacZ mice. Fbxo7 isoforms 1
(top band) and 2 (bottom band) are expressed. += non-specific band. Ponceau S was used as total protein loading control. (C) Independent
replicate of p27 expression in equal numbers of sorted EBs from WT and LacZ mice. (D) Quantification of p27 expression relative to total
protein (Ponceau S) (n= 4). (E) Quantitative RT-PCR analysis of p27 mRNA expression relative to cyclophilin in WT and LacZ mice in sorted
EB populations (n= 2, in triplicate).
demonstrate there was significantly less p27 in late-stage
Fbxo7LacZ/LacZ EBs compared with WT (Figure 4D).
Importantly, p27 mRNA expression was equivalent
between WT and mutant orthochromatophilic EB popu-
lations (Figure 4E), indicating that the Fbxo7 effects on
p27 were post-transcriptional. Likewise, mRNA expres-
sion of the erythroid-specific transcription factor NF-E2
and the p27 transactivator GATA-1 was unchanged
between WT and Fbxo7LacZ/LacZ mice (Supplementary
Figures 1I and J1). These data suggest that Fbxo7
stabilizes p27 protein expression, facilitating cell cycle
arrest in vivo.
Mitochondrial loss is delayed in Fbxo7LacZ/LacZ mice
It has been argued that a failure to clear mitochondria
can contribute to anaemia. Given the role of Fbxo7 in
mediating mitophagy in other settings, we assayed for
mitochondrial loss during erythropoiesis by staining
BM with Mitotracker DeepRed (Mito), also using
the CD71/Ter119 method. Mitochondrial clearance
occurred primarily at the later EB stages; however, even
from the CD71hi, Ter119hi stage onwards, significantly
more Fbxo7LacZ/LacZ EBs had a higher mitochondrial
load (Figure 5A). This analysis was also undertaken
on peripheral blood, where reticulocytes were analysed
using thiazole orange (TO) and Mito (Figure 5B). Com-
pared with WT littermates, Fbxo7LacZ/LacZ mice had 4.1
times as many reticulocytes with mitochondria (Mito+,
TO+) (Figure 5C).
To investigate this further, CD71hi, Ter119hi cells,
the first population to show increased mitochondrial
load, were purified, separated into membranous and
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Figure 5. Mitochondrial loss is delayed in Fbxo7LacZ/LacZ mice. (A) Percentage of Mitotracker DeepRed positive cells in each EB population
(n= 8). (B) Representative flow cytometry plots of blood cells stained with thiazole orange (TO) and Mitotracker DeepRed (Mito). (C)
Percentage of blood cells in each population in B (n= 9). Cells are early reticulocytes (TO+, Mito+), late reticulocytes (TO+, Mito−),
mitochondria-containing RBCs (TO−, Mito+), and mature RBCs (TO−, Mito−). (D) Immunoblots of the cytosol (cyto) and membranous (memb)
fraction from pooled samples of sorted CD71hi, Ter119hi EBs from WT and LacZ mice. Mitochondrial markers, CVα and PDH E1α, are present
in the membranous fraction, whereas GADPH is enriched in the cytosolic fraction. (E) Percentage of Mito+ cells in whole blood over 3 days
in culture, with or without 30 μM CCCP and 160 μM bafilomycin A1 (Baf), from WT and LacZ animals (n= 3).
cytosolic fractions, and immunoblotted (Figure 5D). As
previously reported, Fbxo7 is predominantly cytoso-
lic and a minority is present in the membranous frac-
tion [14,23]. Consistent with a delay in mitochondrial
clearance and altered mitophagic flux, autophagy (p62
and LC3-II) and lysosomal (LAMP2) proteins were
elevated in Fbxo7LacZ/LacZ cells compared with WT.
One explanation for this could be that Fbxo7 affects
Nix recruitment. However, equal amounts of Nix were
detected in the mitochondria-containing fraction from
WT and Fbxo7LacZ/LacZ mice. Likewise, Fbxo7 interac-
tors, Parkin and PINK1, were unchanged in EBs with
reduced Fbxo7. These data show that Fbxo7 does not
affect the localization of known mitophagy initiators
during erythroid differentiation, but mitophagic clear-
ance was either delayed or deficient.
To differentiate between these possibilities,
we tested mitochondrial loss in cultured blood
(Figure 5E). Fbxo7LacZ/LacZ mice had significantly
more mitochondria-containing cells at day 0, but by
day 3, both WT and Fbxo7LacZ/LacZ cells had lost the
majority of their mitochondria. CCCP treatment to
stimulate mitophagy caused loss of mitochondria in WT
and Fbxo7LacZ/LacZ cells by day 1 and this was inhib-
ited by bafilomycin A1 treatment, indicating that the
mitophagic pathway in these cells was intact. Notably,
bafilomycin treatment alone had no effect on mitochon-
dria loss in either WT or LacZ cells, suggesting that
additional mitophagy pathways were active. Collec-
tively, these data demonstrate that mitophagy proceeds
to completion in Fbxo7LacZ/LacZ cells and suggest that
the increased mitochondrial load seen throughout
differentiation is not due to any intrinsic defect. Fur-
thermore, it indicates that reticulocytosis was due to
increased/early release of mitochondria-containing
reticulocytes from the BM, rather than their accumula-
tion in the periphery, a finding supported by the lack of
Mito+, TO− cells in the periphery (Figure 5C). These
data argue against mitophagic defects underlying the
anaemia in Fbxo7LacZ/LacZ mice.
Fbxo7 Ile115 binds p27 less efficiently
A GWAS study reported that an SNP (rs11107) caus-
ing a Met115Ile change in Fbxo7 is associated with
a 0.35-fl decrease in MCV [11]. Given our findings,
we tested whether p27 binding was sensitive to this
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Figure 6. Fbxo7 expressing Ile115 is less able to bind p27. (A) Immunoblots of GST or GST-p27 (1–109) bound T7-Fbxo7 (1–398) expressing
Met115 or Ile115. Increasing doses of in vitro transcribed and translated Fbxo7 were added to the reaction mixes. (B) Quantification of
p27 bound truncated (1–398) or full length (1–522) Fbxo7 expressing Met115 or Ile115, relative to input and expressed as a percentage
of Fbxo7 Met115. (C) Immunoblots of MEL cells expressing human Fbxo7 Met115, Fbxo7 Ile115 or empty vector, in control or murine
Fbxo7 knockdown (KD) cells. (D) Quantification of p27 protein expression in the cells described in C (n= 3). (E) Population doubling of the
DMSO-treated cells described in C (n= 3).
residue in Fbxo7. In vitro binding assays were per-
formedwith GST-p27 protein, incubated with T7-Fbxo7
with Met115 or Ile115 (Figure 6A). Fbxo7(1–398)
Ile115 was 61.5% reduced in p27 binding compared
with Fbxo7(1–398) Met115 after normalizing for input
(Figure 6B). Similarly, full length Fbxo7(1–522) Ile115
was reduced (12.6%) in binding p27, but the difference
was less pronounced, suggesting that the C-terminus sta-
bilized their interaction.
We next tested the effect of the Met115Ile SNP
in MEL cells. Endogenous murine Fbxo7, which
has Ile115, was reduced using stable expression of
shRNA, and human Fbxo7-HA with either Met115 or
Ile115, which are resistant to murine shRNA, was then
expressed. p27 levels were determined in these cells
by immunoblotting (Figure 6C) and then quantified
(Figure 6D). We noted that the human Fbxo7 alleles
were equivalently expressed in MEL cells, although at a
much lower level than endogenous Fbxo7. Importantly,
significantly less p27 was found in Fbxo7 KD cells
expressing Fbxo7 Ile115 compared with Fbxo7 Met115
(cf. lanes 3 and 4, Figure 6C). Furthermore, the amount
of p27 in cells expressing human Fbxo7 Met115 was
comparable to the endogenous murine Fbxo7 Ile115 in
the control cell line, despite its more abundant expres-
sion. This suggests that the Met115 allele of Fbxo7 is
much more effective at stabilizing p27 than the human
or murine Fbxo7 Ile115 alleles.
These MEL cells were treated with DMSO for 7
days and the number of population doublings (PDs)
counted (Figure 6E). Cells with reduced expression
of endogenous Fbxo7 (KD+ vector) underwent signif-
icantly more PDs after DMSO treatment compared with
control cells (vector+ vector), indicating inefficiency in
cell cycle withdrawal. Although human Fbxo7 Ile115
failed to suppress this effect, human Fbxo7 Met115
reduced the number of PDs to a number compara-
ble to control cells. Together, these data demonstrate
that Fbxo7 Ile115 binds and stabilizes p27 less well
than Met115.
Discussion
Our study reports on the physiological regulation of ery-
thropoiesis by Fbxo7/PARK15. Importantly, this is a
non-canonical function of Fbxo7 and acts via its abil-
ity to stabilize p27 levels, and thereby act as a cell
cycle regulator. p27 inhibits CDK2, enabling termi-
nally differentiating EBs to exit the cell cycle to form
mature RBCs. Erythropoiesis requires the coordination
of multiple pathways to enable the production of vast
numbers of RBCs over a person’s lifetime [24]. It is
exquisitely sensitive to even small inefficiencies in the
cell cycle, since minor defects amplified at this scale
often show dramatic phenotypes. For example, stud-
ies on cyclin D3 KO mice showed that 0.7 fewer cell
divisions per cell during terminal differentiation led to
anaemia [3]. Mice with elevated CDK2 activity due
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to a hyper-stable cyclin E are also anaemic [2]. The
requirement for p27-mediated inhibition of CDK2 activ-
ity during erythropoiesis, allowing for cell cycle exit,
has been previously reported [25,26]. Here we show that
Fbxo7 stabilizes p27 levels to ensure cell cycle arrest
and that reduced Fbxo7 expression results in anaemia.
Our study eliminates transcriptional effects on p27,
GATA1 or NF-E2 as underlying causes for anaemia but
as Fbxo7 is a multi-functional E3 ubiquitin ligase, we
cannot eliminate the possibility that it may also act via
p27-independent mechanisms.
In considering other causes for the anaemia in
Fbxo7LacZ/LacZ mice, we reasoned that Fbxo7 also par-
ticipates in mitophagy [7], and defects in mitophagy
can lead to retention of mitochondria in RBCs, leading
to their premature death due to accumulated ROS. Mice
with cell cycle defects, such as the hyper-stable cyclin E
mouse, and consequential high CDK2 activity, also have
defects in mitophagy, which are attributed to a failure
to up-regulate Nix [27]. We noted that in Fbxo7LacZ/LacZ
mice, mitochondrial load was higher from the CD71hi,
Ter119hi (baso-EB) stage onwards and cells had elevated
levels of autophagy pathway components, p62, LC3-II,
and LAMP2. Although this might suggest defects in
mitophagy, reticulocytes from Fbxo7LacZ/LacZ mice
cleared mitochondria under both normal and depolariz-
ing conditions, indicating that mitophagy can proceed
efficiently. Moreover, all of the mitophagy regulators
tested were expressed and appropriately localized in
Fbxo7LacZ/LacZ EBs. The observed increase in mito-
chondrial load may stem from a delay in the induction
of mitophagy, since this process can be temporally
linked to cell cycle withdrawal, which is perturbed in
these mice. Alternatively, a failure to down-regulate
mitochondrial biogenesis might result in increased
load.
CDK6 down-regulation occurs early, initiating the
differentiation programme of EBs, which includes gene
expression changes [8,21,28,29]. In in vitro experi-
ments with MEL cells, we showed that CDK6 was
down-regulated in Fbxo7-deficient cells, showing that
the Fbxo7 activity promoting differentiation was dis-
tinct from CDK6 down-regulation. However, it has
been proposed that CDK6 down-regulation alone is not
sufficient and that CDK2 inhibition is necessary [28,29],
which our experiments support. The cause of increased
early-stage EBs in Fbxo7LacZ/LacZ mice is unknown, but
is unlikely to be due to excessive proliferation, since
pro-EBs from Fbxo7LacZ/LacZ mice have fewer cells
with greater than 2N DNA content than WT cells. It is
possible that increased progenitors are a consequence
of a block in differentiation at the pro-EB stage. Alter-
natively, defective cell cycle arrest at later stages in vivo
may cause a bottleneck effect during differentiation,
perhaps with EBs competing for niches within the BM,
causing an accumulation of upstream progenitors.
Signs of prolonged anaemia resulting in hypoxia,
chronic Epo production, increased erythropoiesis, and
EMH, as well as LT-HSC depletion [30], are all present
in Fbxo7LacZ/LacZ mice. Aged mice are also anaemic
and show other myeloid changes. We hypothesize that
lower LT-HSC numbers may be due to chronic anaemia,
although a cell-intrinsic role for Fbxo7 in LT-HSC
homeostasis cannot be excluded. It should be noted that
mice lacking p27 show no differences in HSC number
or erythroid populations [31].
Fbxo7 function in erythropoiesis is clinically relevant,
and our study provides a potential mechanism to explain
why the Met115Ile SNP is associated with alterations in
RBC MCV [11], although our analyses are more diffi-
cult due to species differences between human (Met115)
and murine (Ile115) Fbxo7. In comparing the human
Fbxo7 alleles, we found that the Fbxo7 Met115 was
significantly more efficient in binding and stabilizing
p27 than Ile115, in vitro and in cells. We hypothesize
that since it binds p27 less well, humans expressing the
minor Fbxo7 Ile115 allele would have decreased p27
levels. Since p27 helps to set the inhibitory threshold
for entry into S, a reduction in its levels may lead to a
reduced time in G1, which correlates with reduced RBC
size. This may manifest as decreased MCV in patients.
By contrast, Fbxo7LacZ/LacZ mice show increased MCV
and MCHC parameters in peripheral blood counts. We
propose that the ∼90% reduction in Fbxo7 in mutant
mice is a more severe phenotype, causing anaemia,
than inheritance of rs11107 SNP, which does not. This
anaemia is accompanied by EMH and reticulocytosis,
and we hypothesize that elevated numbers of larger,
immature cells in the peripheral blood contribute to
these increased parameters observed in the mouse
model.
As can be gleaned from this and other studies, the
erythroid lineage is sensitive to cell cycle perturbations.
One implication from our study is that, depending on
the underlying molecular defect, mild intervention with
the cell cycle would enhance RBC production. One
area for further study would be to determine whether
inhibiting proteins that impact on p27 levels, such as
the SCFSkp2 ubiquitin ligase that targets its degradation,
or, alternatively, Cdk2 inhibition might aid terminal
differentiation and improve erythropoiesis. We propose
that Fbxo7 should be included in this category, as it
impacts on p27 to affect erythropoiesis.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Figure S1. (A) Percentage of LSK (Lineage−, Sca-1+, c-Kit+), ST-HSCs (LSK, CD34+, Flt3−), and lymphoid-biased progenitor populations (LMPP;
LSK, CD34+, Flt3+, and CLP; Lineage−, IL7Rα+, Flt3+) in BM of wild-type (WT) and Fbxo7LacZ/LacZ (LacZ) mice. (B) Percentage of myeloid-biased
progenitor populations (CMP; Lineage−, Sca-1−, c-kit+, CD34+, FcγRII/III−, and GMP; Lineage−, Sca-1−, c-kit+, CD34+, FcγRII/III+) in WT and
LacZmice. (C) Number of (i) mature erythroid burst-forming units (BFU-E) and (ii) erythroid colony-forming units (CFU-E) per 2× 105 BM cells after
3 days in culture (n= 3, in duplicate). (D) Percentage of EBs inWT and LacZmice based onCD71 and Ter119 staining (n= 6). (E) Quantitative RT-PCR
analysis of Fbxo7 mRNA expression (all isoforms) relative to cyclophilin in WT and LacZ mice in sorted EB populations. The number above each bar
indicates percentage relative to WT expression in that cell type (n= 4). (F) Quantitative RT-PCR analysis of Fbxo7 mRNA expression (all isoforms)
relative to cyclophilin in whole organs from WT and LacZ mice. (G) Number of CFUs per 2× 104 spleen cells after 10 days in culture. CFU-M:
macrophage; −G: granulocyte; −GM: mixed granulocyte/macrophage. (H) Quantification of Fbxo7 protein expression in Figure 4B normalized to
Ponceau S and expressed relative to WT isoform 1 expression in CD71hi, Ter119lo EBs. (I, J) Quantitative RT-PCR analysis of GATA1 and NF-E2
mRNA expression respectively, relative to cyclophilin, in sorted EB populations from WT and LacZ mice.
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